EP Lab

This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.

News | Left Atrial Appendage (LAA) Occluders

July 22, 2020 — The U.S. Food and Drug Administration (FDA) has approved Boston Scientific's next generation Watchman ...

Home July 22, 2020
Home
News | EP Lab

July 13, 2020 - The U.S. Food and Drug Administration (FDA) has approved Abbott's next-generation Gallant implantable ...

Home July 13, 2020
Home
Older Critically Ill COVID-19 Patients May Have Increased Risk of Bradycardia With Lopinavir and Ritonavir.
Feature | Coronavirus (COVID-19)

July 9, 2020 — Older, critically ill patients with COVID-19 (SARS-CoV-2) who received a combination of the ...

Home July 09, 2020
Home
News | Implantable Cardiac Monitor (ICM)

July 7, 2020 – Medtronic announced it received U.S. Food and Drug Administration (FDA) clearance and European CE mark ...

Home July 07, 2020
Home
News | Implantable Cardiac Monitor (ICM)

June 29, 2020 — Boston Scientific received U.S. Food and Drug Administration (FDA) 510(k) clearance for the LUX-Dx Inser ...

Home June 29, 2020
Home
Blog | Coronavirus (COVID-19)

Prior to January 2020 when clinicians read about the history of the 1918 flu, and epidemiologists predicted we were ...

Home June 22, 2020
Home
News | Pacemakers

June 16, 2020 - Biotronik has today announced its commitment to giving physicians additional tools to pace in the His ...

Home June 16, 2020
Home
News

June 16, 2020 – The Montreal Heart Institute (MHI) and Thermedical, a developer of thermal-ablation systems to treat ...

Home June 16, 2020
Home
The FDA has determined chloroquine and hydroxychloroquine are not effective at treating novel coronavirus and revoked its earlier emergency use authorization (EUA) for the drugs to be used in COVID-19 patients. FDA says hydroxychloroquine does not work to treat COVID-19.Getty Images #COVID19 #COVID19update #SARSCoV2
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

June 15, 2020 — The U.S. Food and Drug Administration (FDA) today revoked the emergency use authorization (EUA) that ...

Home June 15, 2020
Home
Russian interventional cardiologist Alexey Pankov in full personal protective equipment (PPE) for a cath lab procedure in Moscow during the COVID-19 era. Right, an image of the COVID-19 virus from the National Institutes of Health (NIH).
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

It was originally thought novel coronavirus (COVID-19, SARS-CoV-2) was primarily a respiratory disorder, but as larger ...

Home June 05, 2020
Home
All coronavirus content continued as the most popular content in May 2020. Two of the major topics included an article on the new Kawasaki-like inflammatory disease that affects children with COVID-19 and articles and videos on the cardiovascular effects of hydroxychloroquine in treating or preventing COVID. #COVID19 #SARScov2
Feature | Dave Fornell, Editor

June 4, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magaz ...

Home June 04, 2020
Home
Societies Issue Guide to Safely Resume Cardiovascular Procedures, Diagnostic Tests. #COVID19 #SARScov2
Feature | Cardiovascular Business

The American College of Cardiology (ACC) together with other North American cardiovascular societies issued a framework ...

Home June 03, 2020
Home
Videos | Coronavirus (COVID-19)

Jay Mohan, D.O., RPVI, interventional cardiology fellow at William Beaumont Hospital, Royal Oak, Michigan, created this ...

Home May 29, 2020
Home
Videos | Coronavirus (COVID-19)

Interview with Andrew D. Krahn, M.D.,FHRS, head of the division of cardiology at St. Paul’s Hospital, and professor of ...

Home May 28, 2020
Home
Subscribe Now